Sanofi

News and Events

Press Releases


September 4, 2025
Media Update: ERS: new data across Sanofi’s immunology pipeline reinforce leadership in respiratory diseases

September 4, 2025
Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis

September 3, 2025
Media Update: EADV: Sanofi builds on legacy in immunology with new data highlighting advances in treatment of chronic inflammatory skin diseases

Upcoming Events

24Oct

2025

Third Quarter 2025

Third quarter 2025 results will be reviewed by management during a live audio webcast with the financial community on October 24, 2025. The presentation will be followed by a Q&A session.

14:30 - 16:00 CET (8:30am – 10am EDT)

Quarterly results


Past Events

31Jul

2025

Second Quarter 2025

Second quarter 2025 results were reviewed by management during a live audio webcast with the financial community on July 31, 2025. The presentation was followed by a Q&A session.

Quarterly results

Discover more

24Apr

2025

First quarter 2025

First quarter 2025 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.
 

Quarterly results

Discover more

30Jan

2025

Fourth Quarter & Full Year 2024 Results

Fourth quarter and full year 2024 results were reviewed by management during a live audio webcast with the financial community on January 30, 2025. The presentation was followed by a Q&A session.  

15:00 - 16:30 CET (9:00am – 10:30am EST)

Quarterly results

Discover more